Heart Failure Updates
1st Edition
Published on 26. September 2003
Book
Hardback
290 pages
978-1-84184-072-7 (ISBN)
Description
Given the ever-advancing development of new pharmacological agents to treat heart conditions, clinicians could use a practical report on newly available treatments. The authors here address that need, profiling every pharmacological therapy in use to date for the treatment of heart failure. Renowned as experts in the field, these prominent academicians give incisive commentary on the state-of-the-art in heart failure, as their text is based on their personal experience with these drugs. Heart Failure Updates is a practical, information-packed reference that is essential for cardiologists, cardiac surgeons and associated specialists, particularly clinical biochemists, clinical pharmacologists, and epidemiologists.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Professional and Professional Practice & Development
Dimensions
Height: 240 mm
Width: 161 mm
Thickness: 20 mm
Weight
605 gr
ISBN-13
978-1-84184-072-7 (9781841840727)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
John J. V. McMurray | Marc Pfeffer
Heart Failure Updates
E-Book
09/2003
CRC Press
€69.99
Available for download
John J. V. McMurray | Marc Pfeffer
Heart Failure Updates
E-Book
09/2003
1st Edition
CRC Press
€69.99
Available for download
Persons
John JV McMurray, MD, FRCP
Professor of Medical Cardiology
Honorary Consultant Cardiologist
Western Infirmary
And MRC Clinical Research Initiative in Heart Failure
University of Glasgow
Glasgow, UK
Marc A Pfeffer, MD, PhD
Cardiovascular Division
Brigham and Women's Hospital
Boston MA, USA
Professor of Medical Cardiology
Honorary Consultant Cardiologist
Western Infirmary
And MRC Clinical Research Initiative in Heart Failure
University of Glasgow
Glasgow, UK
Marc A Pfeffer, MD, PhD
Cardiovascular Division
Brigham and Women's Hospital
Boston MA, USA
Content
Anticytokine Therapy: What Went Wrong? Heart Failure Due to Diastolic Dysfunction: Definition, Diagnosis and Treatment. Omaptrilat: The Potential of Vasopeptidase Inhibition. Angiotensin Receptor Blockers: ELITE, ValHEFT and Where Next? Atrial Fibrillation and Heart Failure: Etiological, Prognostic and Therapeutic Considerations. Endothelin Receptor Antagonists: Will They Join the Therapeutic Armamentarium? Betablockers: Mandatory for All? Aldosterone Receptor Blockade: Is There an Opportunity for Further Blockade in Patients with Heart Failure Treated with Standard Therapy Including an ACE-Inhibitor and a Beta Adrenergic Blocking Agent? Nurse Intervention: Can Our Patients Do Without It? Innovative Surgery: A New Dawn in Heart Failure? The Era of Devices? Biventricular Pacing and ICDs. New Treatments for Heart Failure: Successes and Failures. Metabolic Co-morbid Conditions in Chronic Heart Failure: Diabetes and Hypercholesterolemia. BNP: A Blood Test for the Diagnosis of Heart Failure and Monitoring of Its Treatment?